New diabetes shot could cut injections to once a month
Disease control
Not yet recruiting
This study tests a new, long-acting form of semaglutide (a diabetes drug) that is given once every four weeks instead of weekly. The goal is to see if it is safe and works well for controlling blood sugar and weight in 24 adults with type 2 diabetes. Participants must already be …
Phase: PHASE1, PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC